Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis



Serum globulin is an inflammation marker. To date, no evidence regarding the association between serum globulin and disease activity in patients with ulcerative colitis has been reported.


We evaluated the association between serum globulin and endoscopic activity in patients with ulcerative colitis.


Serum globulin was divided into tertiles based on the distribution of study subjects (low globulin, ≤ 2.7 g/dl (reference); moderate globulin, 2.7–3.1 g/dl; and high globulin, > 3.1 g/dl). A single endoscopic specialist evaluated the endoscopic findings, and mucosal healing was based on Mayo endoscopic subscore.


A total of 277 patients with ulcerative colitis were included in the study. Serum globulin was independently positively associated with diminished or absent vascular markings [moderate: adjusted odds ratio (OR) 3.70 (95% confidence interval, CI: 1.82–7.88) and high: adjusted OR 2.40 (95%CI: 1.20–4.94), p for trend = 0.005]. A similar positive association between globulin and erosion was found [high: adjusted OR 2.00 (95%CI: 1.05–3.86)]. Serum globulin was independently inversely associated with mucosal healing [moderate: adjusted OR 0.37 (95%CI: 0.18–0.73) and high: adjusted OR 0.31 (95%CI: 0.14–0.64), p for trend = 0.001] and adjusted partial mucosal healing [moderate: OR 0.51 (95%CI: 0.26–0.98), p for trend = 0.048]. The inverse association between globulin and mucosal healing was significant in the low but not the high C-reactive protein group.


In patients with ulcerative colitis, serum globulin was significantly positively associated with endoscopic activity, and was significantly inversely associated with mucosal healing, especially in the low C-reactive protein group.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2


  1. 1.

    Langholz E, Munkholm P, Davidsen M et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3–11

    CAS  Article  Google Scholar 

  2. 2.

    Colombel JF, Rutgeerts P, Reinisch W et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011;141:1194–1201

    CAS  Article  Google Scholar 

  3. 3.

    Frøslie KF, Jahnsen J, Moum BA et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007;133:412–422

    Article  Google Scholar 

  4. 4.

    Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis 2010;16:338–346

    Article  Google Scholar 

  5. 5.

    Peyrin-Biroulet L, Ferrante M, Magro F et al. Results from the 2nd scientific workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011;5:477–483

    Article  Google Scholar 

  6. 6.

    Sandborn WJ, Panés J, Zhang H et al. Correlation between concentrations of fecal calprotectin and outcomes of patients with ulcerative colitis in a phase 2 trial. Gastroenterology 2016;150:96–102

    CAS  Article  Google Scholar 

  7. 7.

    Shah SC, Colombel JF, Sands BE et al. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016;14:1245–1255

    Article  Google Scholar 

  8. 8.

    Colombel JF, D’Hasens G, Lee WJ et al. Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. J Crohns Colitis 2020;14:254–266

    Article  Google Scholar 

  9. 9.

    H. Kenneth Walker. Clinical Methods: The History, Physical and Laboratory Examinations. 3rd ed. Butterworth-Heinemann, London, 1990; 497–499

  10. 10.

    Feinstein AR, Petersdorf RG. The clinical significance of hyperglobulinemia. Ann Intern Med 1956;44:899–924

    CAS  Article  Google Scholar 

  11. 11.

    Hodgson HJ, Jewell DP. The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels. Am J Dig Dis 1978;23:123–128

    CAS  Article  Google Scholar 

  12. 12.

    Gryboski JD, Spiro HM. Prognosis in children with Crohn’s disease. Gastroenterology 1978;74:807–817

    CAS  Article  Google Scholar 

  13. 13.

    Ordás L, Eckmann L, Talamini M et al. Ulcerative colitis. Lancet 2012;380:1606–1619

    Article  Google Scholar 

  14. 14.

    Scheller J, Garbers C, Rose-John S. Interleukin-6 from basic biology to selective blockade of proinflammatory activities. Semin Immunol 2013;26:2–12

    Article  Google Scholar 

  15. 15.

    Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res 2018;16:26–42

    Article  Google Scholar 

Download references


The authors would like to thank Shogo Kitahata, Yu Hashimoto, Masakazu Hanayama, Kazuhiro Tange, Kanako Konishi, Tomoe Kawamura, Hideomi Tomida, Yasunori Yamamoto, Tomo Kogama, Masumi Hino, and Keiko Kikuchi for their support.

Author information



Corresponding author

Correspondence to Shinya Furukawa.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Shiraishi, K., Furukawa, S., Yagi, S. et al. Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis. Dig Dis Sci (2021).

Download citation


  • Globulins
  • Ulcerative colitis
  • Endoscopy
  • Biomarkers